Lake Zurich-based Fresenius Kabi Tuesday announced the immediate availability of Romidepsin for Injection in the United States, the newest addition to the company’s broad portfolio of injectable cancer medicines.
Related posts
-
Falkenberg sworn in to succeed Solberg on village council
The Palatine Village Council appointed Joe Falkenberg to the District 4 seat recently vacated. -
Bears now considering South Side lakefront site for new stadium
Determined to stay in Chicago and stymied at their preferred lakefront site, the Bears are at... -
MT Barrels in Schaumburg closes again after 2018 reprieve
After bouncing back from a total shutdown in September 2018, MT Barrels Sports Bar & Entertainment...